Abstract
The nitric oxide (NO)/cyclic GMP signaling system regulates both vascular and cardiac function in fundamental ways. Vascular tone is dynamically regulated by vascular smooth muscle cell contractile state. The main effector of NO/cGMP action in cardiovascular target tissues is cyclic GMP-dependent protein kinase I (PKG), a cGMP-activated serine-threonine kinase with multiple targets in vascular and cardiac cells. In the vasculature, the NO/cGMP/ PKG signaling system is the most important endogenous vasodilator system known. Vascular contraction by many agonists is mediated by Gq-coupled receptor activation, calcium mobilization and myosin light chain (MLC) phosphorylation. Nitric oxide (NO) inhibits vascular contraction by activating PKGIα, which both attenuates calcium mobilization by GPCR and activates myosin phosphatase (PP1M), causing dephosphorylation of myosin light chain and VSMC relaxation. We have shown that PKGIα binds directly to the MBS subunit of the PP1M phosphatase. PKGIα also attenuates signaling by Gq-coupled receptors via a direct interaction with the regulator of G-protein signaling, RGS2, which PKGI phosphorylates and activates to terminate Gq-coupled receptor-mediated signaling. The N-terminal leucine zipper (LZ) of PKGIα mediates its interaction with PP1M and RGS2. To explore the role of PKGIα in blood vessels and heart, we used gene targeting several years ago to create mice that express a LZ mutant (LZM) form of PKGIα in which critical amino acids in the leucine zipper motif have been substituted to disrupt LZ binding. Newer studies of these mice will be described. VSMC from PKGIα mutant mice display multiple phenotypic abnormalities in culture. In addition, PKGIα-mediated regulation of Rho/Rho kinase signaling is disrupted in intact VSMC from LZM mice. Blood vessels from PKG1α mutant mice relax abnormally and intact PKG1α mutant mice have systemic hypertension, without detectable abnormalities of renal function. New data regarding PKGIα and myocardial function in wild type and LZM mice will also be discussed. These data demonstrate the central importance of PKGIα signaling in maintenance of normal vascular physiology and blood pressure, and in the regulation of myocardial hypertrophy.
Highlights
3rd International Conference on cGMP Generators, Effectors and Therapeutic Implications Meeting abstracts – A single PDF containing all abstracts in this Supplement is available here.
Vascular contraction by many agonists is mediated by Gq-coupled receptor activation, calcium mobilization and myosin light chain (MLC) phosphorylation
We have shown that PKGIα binds directly to the MBS subunit of the PP1M phosphatase
Summary
3rd International Conference on cGMP Generators, Effectors and Therapeutic Implications Meeting abstracts – A single PDF containing all abstracts in this Supplement is available here. . Regulation of cardiovascular physiology by cyclic GMP-dependent protein kinase Iα Address: Tufts University School of Medicine, Tufts-New England Medical Center, Boston, MA, USA Email: Michael E Mendelsohn* - mmendelsohn@tufts-nemc.org * Corresponding author from 3rd International Conference on cGMP Generators, Effectors and Therapeutic Implications Dresden, Germany.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.